🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
17.10
-0.08 (-0.47%)
Nov 18, 2026, 1:50 PM EST - Market open

Immunome Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
212.84653.48143.3598.6820.3249.23
Short-Term Investments
248.74-73.9539.46--
Cash & Short-Term Investments
461.58653.48217.3138.1420.3249.23
Cash Growth
69.30%200.72%57.30%579.73%-58.72%23.80%
Accounts Receivable
-----1.64
Other Receivables
2.8---0.852.67
Receivables
2.8---0.854.31
Prepaid Expenses
13.417.34.046.561.032.51
Other Current Assets
----0.450.59
Total Current Assets
477.8660.78221.34144.722.6556.64
Property, Plant & Equipment
20.5517.6114.393.640.970.86
Long-Term Deferred Charges
----0.330.33
Other Long-Term Assets
7.184.84.510.20.10.1
Total Assets
505.53683.19240.24148.5424.0557.93

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4.463.3414.193.312.43.08
Accrued Expenses
32.2738.0325.146.984.624.31
Current Portion of Leases
1.13-0.060.310.23-
Current Unearned Revenue
--6.9410.49--
Other Current Liabilities
3.113.637.980.730.092.34
Total Current Liabilities
40.9744.9954.3121.837.339.73
Long-Term Leases
10.263.864.771.340.06-
Long-Term Unearned Revenue
---5.49--
Other Long-Term Liabilities
-----0.01
Total Liabilities
51.2248.8559.0828.667.399.74

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.01000
Additional Paid-In Capital
1,3961,362696.87342.66132.65127.29
Retained Earnings
-940.91-728.16-515.77-222.81-116-79.11
Comprehensive Income & Other
-0.47-0.060.02--
Total Common Equity
454.3634.34181.17119.8816.6548.19
Shareholders' Equity
454.3634.34181.17119.8816.6548.19
Total Liabilities & Equity
505.53683.19240.24148.5424.0557.93

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
11.393.864.831.650.29-
Net Cash (Debt)
450.2649.63212.47136.4920.0349.23
Net Cash Growth
67.59%205.75%55.67%581.37%-59.31%25.74%
Net Cash Per Share
4.147.443.626.881.654.27
Filing Date Shares Outstanding
118.07113.1386.9559.6912.2212.13
Total Common Shares Outstanding
113.65113.1364.4643.2512.1312.11
Working Capital
436.83615.79167.03122.8715.3246.91
Book Value Per Share
4.005.612.812.771.373.98
Tangible Book Value
454.3634.34181.17119.8816.6548.19
Tangible Book Value Per Share
4.005.612.812.771.373.98
Machinery
-11.299.935.753.943.69
Construction In Progress
-5.553.3---
Leasehold Improvements
-4.161.640.230.190.19
SEC Filings: 10-K · 10-Q